| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T396 |
0-158 |
Sentence |
denotes |
B cell response has a temporal dynamic to human infecting CoVs, with a median time of detection for SARS-CoV as 14 days, reviewed by Huang A.T. et al. (2020). |
| T397 |
159-416 |
Sentence |
denotes |
The peak antibody titer for IgG and IgM, and detection time of neutralizing antibody varied across studies with a lower time point of seroconversion for IgG, IgM, and IgA as 15 days (Hsueh et al., 2004; Mo et al., 2006; Cao et al., 2007; Yang et al., 2009). |
| T398 |
417-504 |
Sentence |
denotes |
A more dynamic range of seroconversion was observed in sera from the COVID-19 patients. |
| T399 |
505-686 |
Sentence |
denotes |
A study by Liu X. et al. (2020) on 32 patients with varying disease severity has shown detectable IgM antibodies from day four and peaked at day 20, since the onset of the symptoms. |
| T400 |
687-763 |
Sentence |
denotes |
At the same time, IgG antibodies appeared after day 7 with a peak on day 25. |
| T401 |
764-884 |
Sentence |
denotes |
When compared to the disease severity, mild cases had peak IgM response earlier than in severe cases (day 17 vs day 21). |
| T402 |
885-1017 |
Sentence |
denotes |
Further, severe cases exhibited more robust IgG antibody response than mild cases, as will be discussed in the subsequent section C. |
| T403 |
1018-1295 |
Sentence |
denotes |
In terms of the antibody response seen after symptom onset, a similar trend was shown by Liu X. et al. (2020) who detected IgM antibodies in SARS-CoV-2 infected patients between 3 and 6 days and IgG antibodies after day 8 of symptom onset, irrespective of the disease severity. |
